-transparent.png){kind=logo}
Since factor(s) present in human pregnancy sera may interfere with HLA-DR expression on antigen-presenting cells which could account for fetal immune tolerance, we decided to investigate HLA-DR expression on the human myeloid macrophage cell line U937 using the monoclonal antibody RF DR2 and flow cytometry. Following incubation of U937 cells with recombinant interferon gamma (rIFN gamma) and fetal calf serum, 76% of the cells were HLA-DR positive. In contrast, when U937 cells were incubated with retroplacental serum (RP) only 40% of them were positive for HLA-DR and the mean fluorescent intensity for the cell population was significantly diminished. By performing these experiments at 37 and at 4 degrees C we concluded that a factor or factors present in RP bind onto and mask class II major histocompatibility (MHC) antigen expression.
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
December 1988,
Journal of the American Academy of Dermatology,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
April 1987,
Proceedings of the National Academy of Sciences of the United States of America,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
February 1989,
The Journal of clinical investigation,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
January 1988,
Hepatology (Baltimore, Md.),
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
July 1988,
Journal of clinical immunology,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
January 1987,
Critical reviews in immunology,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
June 1986,
Transplantation,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
February 1998,
Veterinary immunology and immunopathology,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
February 1989,
Transplantation proceedings,
N S Nicholas, and
G S Panayi, and
J Murphy, and
C Pitzalis
July 1985,
Immunological reviews,
